Britannia Equity Research
Britannia Equity Research
Britannia Equity Research
Britannia Industries
4Q lags other food cos, guiding for strong 1Q REDUCE
Britannia (BRIT) clocked 2% yoy revenue growth (HSIE -2%) with flat CMP (as on 03 June 2020) Rs 3,510
volume. Co saw growth acceleration (8-10%) in Jan/Feb which was better than
Target Price Rs 2,852
what it clocked in 9MFY20 (5% yoy growth). Lockdown led supply chain
disruption impacted primary performance in March. Pantry loading NIFTY 10,062
supported other foods businesses in Q4 as Nestle and Marico’s Saffola posted
KEY
11% and 25% yoy growth which BRIT missed. However, BRIT’s recovery in OLD NEW
CHANGES
April/May was strong (24% yoy) owing to (1) Benefits of high home
Rating REDUCE REDUCE
consumption (April/May consumer offtake at ~20% for BRIT), (2) Market
share gain (particularly in Hindi belt), (3) Channel filling (~3% support), (4) Price Target Rs 2,711 2,852
Quicker resumption of plants and supply chain than peers, and (5) Support FY21E FY22E
EPS %
from deeper distribution reach. With consumers refraining from eating +6% +5%
outside, we expect Britannia to deliver healthy growth in 1HFY21, before
aggregate demand pressure kicks-in in 2HFY21. Cost control and moderation
KEY STOCK DATA
in RM inflation will sustain EBITDA margin in FY21. We increase EPS
estimate by 6/5% for FY21/FY22. However, we remain cautious due to Bloomberg code BRIT IN
rich valuations (47x FY22 P/E) coupled with group company investments (via No. of Shares (mn) 240
ICD), rising gross debt and non-current investments. We value BRIT at 38x MCap (Rs bn) / ($ mn) 844/11,187
P/E on Mar-22E EPS, and derive a TP of Rs 2,852. Maintain REDUCE.
6m avg traded value (Rs mn) 1,961
▪ Marginal beat in revenue: Consolidated revenue saw a growth of 2% yoy to 52 Week high / low Rs 3,708/2,100
Rs 28.67bn (+10% in 4QFY19 and 5% in 3QFY20) vs exp. decline of 2%. We
expect flat volume in 4Q (+7% in 4QFY19 and +2% in 3QFY20) vs. est decline
STOCK PERFORMANCE (%)
of 4%. Co saw healthy growth in Jan/Feb (8-10% growth) after moderate
performance in 9MFY20 (5%). Market share gain in biscuits continued for 3M 6M 12M
the co as it increased the gap from the second placed player. However, the Absolute (%) 16.0 15.2 18.2
sudden lockdown impacted revenue and net profit for Britannia by 7-10%. Relative (%) 27.7 31.3 33.5
The expanding rural reach will also aid co as rural economy is expected to
do better than urban in the near term.
SHAREHOLDING PATTERN (%)
▪ EBITDA growth of 4%: GM dipped by 152bps yoy (+273bps in 4QFY19 and Dec-19 Mar-20
-44bps in 3QFY20) to 39.7% (HSIE 40.6%) as RM inflation sustained
Promoters 50.63 50.63
(particularly dairy and palm oil) in 4Q. Employee/Other expenses were up
by +12/-9% yoy. EBITDAM expanded by 24bps yoy (-5bps in 4QFY19 and FIs & Local MFs 13.56 13.38
+94bps in 3QFY20) to 15.8%. EBITDA grew by 4% yoy (+10% in 4QFY19 and FPIs 15.79 14.71
+11% in 3QFY20) to Rs 4.54bn (exp Rs 4.19bn). PAT grew by 27% yoy to Rs
Public & Others 20.02 21.28
3.7bn (HSIE Rs 3.2bn) owing to lower taxes.
Pledged Shares 0.00 0.00
Call & other takeaways: (1) Demand picks up in Jan/Feb, (2) All factories,
depots and distributors of the co are operational, (3) Biscuits are expected to Source : BSE
do strong growth due to consumers reducing eating out, (4) New launches
will continue in a gradual manner in FY21, (5) ICDs to group cos are a bit Varun Lohchab
lower than last year (~Rs 6bn). Non-group ICDs saw increase in FY20. [email protected]
+91-22-6171-7334
Financial Summary
4Q 4Q YoY 3Q QoQ
FY19 FY20P FY21E FY22E
Naveen Trivedi
YE Mar (Rs mn)
FY20 FY19 (%) FY20 (%) [email protected]
Net Sales 28,677 27,990 2.5 29,828 (3.9) 1,10,547 1,15,780 1,30,234 1,42,785 +91-22-6171-7324
EBITDA 4,543 4,366 4.1 5,021 (9.5) 17,334 18,433 20,919 23,305
APAT 3,729 2,943 26.7 3,700 0.8 11,555 14,067 15,772 18,053 Aditya Sane
Diluted EPS (Rs) 15.5 12.2 26.7 15.4 0.9 48.1 58.5 65.6 75.1 [email protected]
P/E (x) 73.0 60.0 53.5 46.8 +91-22-6171-7336
EV / EBITDA (x) 47.9 44.6 38.9 34.4
RoCE (%) 39.2 42.8 49.1 55.5
Source: Company, HSIE Research
HSIE Research is also available on Bloomberg ERH HDF <GO> & Thomson Reuters
Britannia Industries: Results Review 4QFY20
Page | 2
Britannia Industries: Results Review 4QFY20
Employee/A&P/Other Exp Other Operating Expenses 4,356 4,772 (8.7) 4,641 (6.1) 18,143 18,186 (0.2)
declined by 35/33/18% owing EBITDA 4,543 4,366 4.1 5,021 (9.5) 18,433 17,321 6.4
to cost rationalisation of Depreciation 485 469 3.3 467 3.8 1,848 1,619 14.2
operating costs and lower EBIT 4,058 3,897 4.1 4,554 (10.9) 16,585 15,702 5.6
marketing reinvestment rate. Other Income 786 618 27.2 652 20.6 2,794 2,078 34.5
Interest Cost 270 13 2,059.2 237 14.0 769 91 746.0
Share of (loss)/profit in
1 (3) na 3 na 4 (10) na
associates
Exceptional items (3) - - 165 -
PBT 4,578 4,499 1.8 4,972 (7.9) 18,449 17,679 4.4
Tax 849 1,557 (45.4) 1,273 (33.3) 4,507 6,125 (26.4)
RPAT 3,729 2,943 26.7 3,700 0.8 13,942 11,556 20.6
Adjustment - - - 125 -
APAT 3,729 2,943 26.7 3,700 0.8 14,067 11,556 21.7
EPS 15.5 12.2 26.7 15 0.9 116.2 96.3 20.6
Source: Company, HSIE Research
All new launches are gross New Launches: Expanding Addressable Market
margin accretive to BRIT
Cream Wafers, Milk Shakes, Salted Snacks and Croissants
Within 1 year of launch BRIT
has become the no 3 player
with ~10% share in cream
wafers (Rs 6bn category)
Page | 3
Britannia Industries: Results Review 4QFY20
Q1FY17
Q2FY17
Q3FY17
Q4FY17
Q1FY18
Q2FY18
Q3FY18
Q4FY18
Q1FY19
Q2FY19
Q3FY19
Q4FY19
Q1FY20
Q2FY20
Q3FY20
Q4FY20
Source: Company, HSIE Research Source: Company, HSIE Research
40.3%
40.6%
40.2%
40.1%
40.3%
40.3%
39.7%
38.4%
130
37.6%
20%
120 111 116 38.5%
35.6%
99
34.3%
91
84 15%
80 69 79 35.0%
62
55 10%
46
40 31.5%
5%
- 0% 28.0%
FY11
FY12
FY13
FY14
FY15
FY16
FY17
FY18
FY19
FY20E
FY21E
FY22E
FY20E
FY21E
FY22E
FY11
FY12
FY13
FY14
FY15
FY16
FY17
FY18
FY19
Page | 4
Britannia Industries: Results Review 4QFY20
16.3%
12.6%
16.1%
12.1%
15.9%
12.1%
15.7%
18.0% 14.0%
15.1%
14.5%
14.1%
10.5%
10.1%
9.8%
9.8%
15.0%
10.5%
11.0%
8.3%
12.0%
9.1%
5.7%
7.0%
6.8%
9.0%
5.7%
4.2%
5.1%
3.6%
2.9%
6.0%
3.5%
3.0%
0.0% 0.0%
FY11
FY12
FY13
FY14
FY15
FY16
FY17
FY18
FY19
FY20E
FY21E
FY22E
FY11
FY12
FY13
FY14
FY15
FY16
FY17
FY18
FY19
FY20E
FY21E
1.26 10.00
1.30 10.00 8.00
1.00 6.60
0.90 5.00
0.50 0.00
FY15
FY16
FY17
FY18
FY19
FY20
FY15
FY16
FY17
FY18
FY19
FY20
Page | 5
Britannia Industries: Results Review 4QFY20
Page | 6
Britannia Industries: Results Review 4QFY20
Assumptions
Particulars (Rs mn) FY15 FY16 FY17 FY18 FY19 FY20P FY21E FY22E
Revenue Growth (%)
Biscuits and high protein food 13.9 10.9 8.0 8.0 11.5 4.0 12.0 8.5
Bread, bread toast and rusk 12.7 12.2 7.0 7.0 15.0 4.0 13.0 11.0
Cake 32.2 18.3 8.0 8.0 15.0 6.0 15.0 13.0
Dairy Business 10.1 (2.2) 2.5 (5.2) 8.0 6.0 6.0 10.0
International Business 23.3 28.1 (13.8) (3.1) 13.0 5.7 8.0 12.0
Gross Margin (%) 40.3 40.3 38.3 38.4 40.6 40.2 40.1 40.3
ASP (% of sales) 8.3 5.3 4.3 4.1 4.5 4.6 4.3 4.4
Distribution (% of sales) 5.4 5.1 4.9 4.9 5.0 5.2 5.0 5.0
EBITDA Margin (%) 11.0 14.5 14.1 15.1 15.7 15.9 16.1 16.3
Tax Rate (%) 27.5 32.5 32.2 33.9 34.6 24.4 25.2 25.2
NPM (%) 8.3 9.8 9.8 10.1 10.5 12.1 12.1 12.6
Change in Estimates
FY21E FY22E
OLD NEW Chg (%) OLD NEW Chg (%)
Net Sales 1,22,506 1,30,234 6.3% 1,33,890 1,42,785 6.6%
EBITDA 19,836 20,919 5.5% 22,271 23,305 4.6%
APAT 14,878 15,772 6.0% 17,146 18,053 5.3%
EPS 61.9 65.6 5.9% 71.4 75.1 5.2%
Page | 7
Britannia Industries: Results Review 4QFY20
Financials
Standalone Income Statement
Year ending March FY15 FY16 FY17 FY18 FY19 FY20P FY21E FY22E
Net Revenues 78,584 83,972 90,541 99,140 1,10,547 1,15,780 1,30,234 1,42,785
Growth (%) 13.7 10.4 7.8 9.5 11.5 4.7 12.5 9.6
Material Expenses 46,918 50,127 55,887 61,071 65,615 69,275 77,997 85,231
Employee Expense 2,806 3,414 3,526 4,016 4,418 4,877 5,354 5,863
ASP Expense 6,517 4,461 3,850 4,113 5,008 5,326 5,535 6,283
Distribution Expense 4,271 4,310 4,459 4,864 5,534 6,021 6,512 7,139
Other Expense 9,433 9,517 10,037 10,059 12,638 11,849 13,918 14,964
EBITDA 8,639 12,144 12,782 15,017 17,334 18,433 20,919 23,305
EBITDA Growth (%) 37.7 40.6 5.3 17.5 15.4 6.3 13.5 11.4
EBITDA Margin (%) 11.0 14.5 14.1 15.1 15.7 15.9 16.1 16.3
Depreciation & Amortisation 1,445 1,134 1,193 1,421 1,619 1,848 2,006 2,191
EBIT 7,194 11,010 11,589 13,596 15,715 16,585 18,913 21,113
Other Income (Including EO Items) 2,340 1,244 1,505 1,664 2,065 2,630 3,144 4,017
Interest 39 49 55 76 91 769 985 1,010
PBT 9,496 12,205 13,040 15,184 17,689 18,445 21,071 24,120
Tax 2,611 3,961 4,197 5,142 6,125 4,507 5,304 6,071
RPAT 6,886 8,246 8,846 10,040 11,555 13,942 15,772 18,053
Adjustment 402 - - - - (125) - -
Adjusted PAT 6,485 8,246 8,846 10,040 11,555 14,067 15,772 18,053
APAT Growth (%) 64.0 27.2 7.3 13.5 15.1 21.7 12.1 14.5
Adjusted EPS (Rs) 27.0 34.4 36.9 41.8 48.1 58.5 65.6 75.1
EPS Growth (%) 64.0 27.1 7.3 13.4 15.0 21.6 12.1 14.5
Source: Company, HSIE Research
Page | 8
Britannia Industries: Results Review 4QFY20
Key Ratios
Particulars FY15 FY16 FY17 FY18 FY19 FY20P FY21E FY22E
PROFITABILITY (%)
GPM 40.3 40.3 38.3 38.4 40.6 40.2 40.1 40.3
ASP 8.3 5.3 4.3 4.1 4.5 4.6 4.3 4.4
EBITDA Margin 11.0 14.5 14.1 15.1 15.7 15.9 16.1 16.3
EBIT Margin 9.2 13.1 12.8 13.7 14.2 14.3 14.5 14.8
APAT Margin 8.3 9.8 9.8 10.1 10.5 12.1 12.1 12.6
RoE 63.5 49.3 36.9 32.9 30.4 32.5 33.3 31.9
RoIC (or Core RoCE) 76.7 74.8 44.1 39.1 39.2 42.8 49.1 55.5
RoCE 54.8 45.9 35.2 31.2 28.9 28.1 26.1 25.9
EFFICIENCY
Tax Rate (%) 27.5 32.5 32.2 33.9 34.6 24.4 25.2 25.2
Fixed Asset Turnover (x) 4.6 4.4 6.4 5.7 4.9 4.4 4.6 4.6
Inventory (days) 18.8 19.2 26.7 24.0 25.8 23.4 22.4 22.4
Debtors (days) 6.3 7.4 7.2 11.2 13.0 10.1 11.0 11.0
Other Current Assets (days) 21.6 26.5 48.5 42.4 49.2 46.7 46.7 46.7
Payables (days) 52.0 42.7 39.6 45.3 49.7 47.5 47.5 47.6
Other Current Liab & Provns (days) 11.8 10.9 10.8 11.1 8.9 9.8 9.8 9.8
Cash Conversion Cycle (days) (17.2) (0.6) 32.0 21.3 29.4 22.9 22.8 22.7
Net D/E (x) (0.5) (0.4) (0.2) (0.3) (0.3) (0.5) (0.6) (0.7)
Interest Coverage (x) 186.4 226.1 212.6 179.1 172.9 21.6 19.2 20.9
PER SHARE DATA (Rs)
EPS 27.0 34.4 36.9 41.8 48.1 58.5 65.6 75.1
CEPS 33.1 39.1 41.8 47.7 54.8 66.2 73.9 84.2
Dividend 8.0 10.0 11.0 12.5 15.0 35.0 22.0 25.0
Book Value 51.9 87.4 112.5 142.0 174.9 185.2 208.7 261.8
VALUATION
P/E (x) 129.9 102.2 95.2 83.9 73.0 60.0 53.5 46.8
P/BV (x) 67.6 40.2 31.2 24.7 20.1 18.9 16.8 13.4
EV/EBITDA (x) 96.8 68.8 65.5 55.4 47.9 44.6 38.9 34.4
EV/Revenues (x) 10.6 9.9 9.3 8.4 7.5 7.1 6.2 5.6
OCF/EV (%) 0.7 1.1 0.5 1.5 1.2 2.2 2.2 2.6
FCF/EV (%) 0.8 0.9 0.1 1.0 0.7 1.8 2.0 2.2
FCFE/Mkt Cap (%) 0.1 0.3 0.3 0.4 0.3 0.6 1.5 1.4
Dividend Yield (%) 0.2 0.3 0.3 0.4 0.4 1.0 0.6 0.7
Source: Company, HSIE Research
Page | 9
Britannia Industries: Results Review 4QFY20
RECOMMENDATION HISTORY
Date CMP Reco Target
Britannia Inds TP 9-Jul-19 2,763 NEU 3,011
11-Aug-19 2,588 NEU 2,674
3,600
22-Sep-19 2,867 BUY 3,433
3,400 11-Oct-19 3,037 BUY 3,620
3,200 15-Nov-19 3,195 BUY 3,513
30-Dec-19 3,042 BUY 3,638
3,000
9-Jan-20 3,001 BUY 3,678
2,800 11-Feb-20 3,156 BUY 3,551
2,600 2-Mar-20 2,970 ADD 3,318
13-Apr-20 2,803 REDUCE 2,711
2,400
14-Apr-20 2,711 REDUCE 2,711
2,200 3-Jun-20 3,510 REDUCE 2,852
2,000 From 2nd March 2020, we have moved to new rating system
Oct-19
Jul-19
Aug-19
Jan-20
Apr-20
Sep-19
May-20
Mar-20
Jun-19
Dec-19
Jun-20
Nov-19
Feb-20
Rating Criteria
BUY: >+15% return potential
ADD: +5% to +15% return potential
REDUCE: -10% to +5% return potential
SELL: >10% Downside return potential
Page | 10
Britannia Industries: Results Review 4QFY20
Disclosure:
We, Varun Lohchab, PGDM, Naveen Trivedi, MBA, & Aditya Sane, CA, authors and the names subscribed to this report, hereby certify that all of the views
expressed in this research report accurately reflect our views about the subject issuer(s) or securities. HSL has no material adverse disciplinary history as on the
date of publication of this report. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific
recommendation(s) or view(s) in this report.
Research Analyst or his/her relative or HDFC Securities Ltd. does not have any financial interest in the subject company. Also Research Analyst or his relative
or HDFC Securities Ltd. or its Associate may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding
the date of publication of the Research Report. Further Research Analyst or his relative or HDFC Securities Ltd. or its associate does not have any material
conflict of interest.
Any holding in stock –NO
HDFC Securities Limited (HSL) is a SEBI Registered Research Analyst having registration no. INH000002475.
Disclaimer:
This report has been prepared by HDFC Securities Ltd and is solely for information of the recipient only. The report must not be used as a singular basis of any
investment decision. The views herein are of a general nature and do not consider the risk appetite or the particular circumstances of an individual investor;
readers are requested to take professional advice before investing. Nothing in this document should be construed as investment advice. Each recipient of this
document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in securities of the companies
referred to in this document (including merits and risks) and should consult their own advisors to determine merits and risks of such investment. The
information and opinions contained herein have been compiled or arrived at, based upon information obtained in good faith from sources believed to be
reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy,
completeness or correctness. All such information and opinions are subject to change without notice. Descriptions of any company or companies or their
securities mentioned herein are not intended to be complete. HSL is not obliged to update this report for such changes. HSL has the right to make changes and
modifications at any time.
This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity who is a citizen
or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, reproduction, availability or use would be
contrary to law or regulation or what would subject HSL or its affiliates to any registration or licensing requirement within such jurisdiction.
If this report is inadvertently sent or has reached any person in such country, especially, United States of America, the same should be ignored and brought to
the attention of the sender. This document may not be reproduced, distributed or published in whole or in part, directly or indirectly, for any purposes or in
any manner.
Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could have an adverse effect on their value or
price, or the income derived from them. In addition, investors in securities such as ADRs, the values of which are influenced by foreign currencies effectively
assume currency risk. It should not be considered to be taken as an offer to sell or a solicitation to buy any security.
This document is not, and should not, be construed as an offer or solicitation of an offer, to buy or sell any securities or other financial instruments. This report
should not be construed as an invitation or solicitation to do business with HSL. HSL may from time to time solicit from, or perform broking, or other services
for, any company mentioned in this mail and/or its attachments.
HSL and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of
the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a
market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any
other potential conflict of interests with respect to any recommendation and other related information and opinions.
HSL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments
made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates,
diminution in the NAVs, reduction in the dividend or income, etc.
HSL and other group companies, its directors, associates, employees may have various positions in any of the stocks, securities and financial instruments dealt
in the report, or may make sell or purchase or other deals in these securities from time to time or may deal in other securities of the companies / organizations
described in this report.
HSL or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject
company for any other assignment in the past twelve months.
HSL or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from the
date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage
services or other advisory service in a merger or specific transaction in the normal course of business.
HSL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with
preparation of the research report. Accordingly, neither HSL nor Research Analysts have any material conflict of interest at the time of publication of this
report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. HSL may
have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of
the subject company. We have not received any compensation/benefits from the subject company or third party in connection with the Research Report.
HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp. Crompton Greaves, Kanjurmarg
(East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022) 2496 5066 Compliance Officer: Binkle R. Oza Email: [email protected] Phone: (022)
3045 3600 HDFC Securities Limited, SEBI Reg. No.: NSE, BSE, MSEI, MCX: INZ000186937; AMFI Reg. No. ARN: 13549; PFRDA Reg. No. POP: 11092018;
IRDA Corporate Agent License No.: CA0062; SEBI Research Analyst Reg. No.: INH000002475; SEBI Investment Adviser Reg. No.: INA000011538; CIN -
U67120MH2000PLC152193
HDFC securities
Institutional Equities
Unit No. 1602, 16th Floor, Tower A, Peninsula Business Park,
Senapati Bapat Marg, Lower Parel, Mumbai - 400 013
Board: +91-22-6171-7330 www.hdfcsec.com
Page | 11